ChloroquineV1, Main, Exploration, bibRecord, 003748

Antimalarials in Rheumatic Diseases

Identifieur interne : 003748 ( Main/Exploration ); précédent : 003747; suivant : 003749

Antimalarials in Rheumatic Diseases

Auteurs : R. O. Day ; P. Sambrook ; G. D. Champion ; G- G. Graham

Source :

Australian and New Zealand Journal of Medicine [ 0004-8291 ] ; 1982-12.

RBID : ISTEX:1873BE578436D6288E218D4FFFFF528745A73B2E

English descriptors

Teeft :
- Adverse effects, Antimalarial, Antimalarials bind, Arthritis, Arthritis rheum, Chloroquine, Clin, Clinical pharmacology, Complement deficiency, Complement system, Creatinine clearance, Cumulative dose, Daily dosages, Daily dose, Discoid lupus, Further studies, Gastrointestinal, Gold thiomalate, Hydroxychloroquine, Immune response, Individual components, Lupus, Lupus erythematosus, Older patients, Ophthalmological examination, Ophthalmological safety, Other drugs, Plasma concentrations, Renal, Renal failure, Retinal toxicity, Rheum, Rheumatic, Rheumatic diseases, Rheumatoid, Rheumatoid anhntis, Rheumatoid arthritis, Semin arthritis rheum, Serum chloroquine, Side effects, Systemic lupus erythematosus, Toxicity, Whole blood.

Abstract

Abstract: The use of antimalarials in rheumatoid arthritis (RA) and systemic lupus erythematosis (SLE) has declined over recent years due to concern over retinal toxicity and the impression that this class of drugs is relatively ineffective in rheumatic diseases. Recent reviewsr‐3 suggest that this position should be changed. Firstly, there is now good evidence for the efficacy of these drugs in RA and secondly strict control of the daily dosage and careful ophthalmological surveillance can almost eliminate the risk of serious retinal toxicity.

Url:

https://api.istex.fr/ark:/67375/WNG-021KZHG7-N/fulltext.pdf

DOI: 10.1111/j.1445-5994.1982.tb02658.x

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 000037
to stream Istex, to step Curation: 000037
to stream Istex, to step Checkpoint: 002507
to stream Main, to step Merge: 003827
to stream Main, to step Curation: 003748

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antimalarials in Rheumatic Diseases</title>
<author><name sortKey="Day, R O" sort="Day, R O" uniqKey="Day R" first="R. O." last="Day">R. O. Day</name>
</author>
<author><name sortKey="Sambrook, P" sort="Sambrook, P" uniqKey="Sambrook P" first="P." last="Sambrook">P. Sambrook</name>
</author>
<author><name sortKey="Champion, G D" sort="Champion, G D" uniqKey="Champion G" first="G. D." last="Champion">G. D. Champion</name>
</author>
<author><name sortKey="Graham, G G" sort="Graham, G G" uniqKey="Graham G" first="G- G." last="Graham">G- G. Graham</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1873BE578436D6288E218D4FFFFF528745A73B2E</idno>
<date when="1982" year="1982">1982</date>
<idno type="doi">10.1111/j.1445-5994.1982.tb02658.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-021KZHG7-N/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000037</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000037</idno>
<idno type="wicri:Area/Istex/Curation">000037</idno>
<idno type="wicri:Area/Istex/Checkpoint">002507</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002507</idno>
<idno type="wicri:doubleKey">0004-8291:1982:Day R:antimalarials:in:rheumatic</idno>
<idno type="wicri:Area/Main/Merge">003827</idno>
<idno type="wicri:Area/Main/Curation">003748</idno>
<idno type="wicri:Area/Main/Exploration">003748</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Antimalarials in Rheumatic Diseases</title>
<author><name sortKey="Day, R O" sort="Day, R O" uniqKey="Day R" first="R. O." last="Day">R. O. Day</name>
<affiliation></affiliation>
<affiliation><wicri:noCountry code="subField">2010</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Sambrook, P" sort="Sambrook, P" uniqKey="Sambrook P" first="P." last="Sambrook">P. Sambrook</name>
<affiliation><wicri:noCountry code="subField">Wales</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Champion, G D" sort="Champion, G D" uniqKey="Champion G" first="G. D." last="Champion">G. D. Champion</name>
<affiliation><wicri:noCountry code="subField">Wales</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Graham, G G" sort="Graham, G G" uniqKey="Graham G" first="G- G." last="Graham">G- G. Graham</name>
<affiliation><wicri:noCountry code="subField">Wales</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Australian and New Zealand Journal of Medicine</title>
<title level="j" type="alt">AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE</title>
<idno type="ISSN">0004-8291</idno>
<idno type="eISSN">1445-5994</idno>
<imprint><biblScope unit="vol">12</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="645">645</biblScope>
<biblScope unit="page" to="649">649</biblScope>
<biblScope unit="page-count">5</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1982-12">1982-12</date>
</imprint>
<idno type="ISSN">0004-8291</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0004-8291</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Adverse effects</term>
<term>Antimalarial</term>
<term>Antimalarials bind</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Chloroquine</term>
<term>Clin</term>
<term>Clinical pharmacology</term>
<term>Complement deficiency</term>
<term>Complement system</term>
<term>Creatinine clearance</term>
<term>Cumulative dose</term>
<term>Daily dosages</term>
<term>Daily dose</term>
<term>Discoid lupus</term>
<term>Further studies</term>
<term>Gastrointestinal</term>
<term>Gold thiomalate</term>
<term>Hydroxychloroquine</term>
<term>Immune response</term>
<term>Individual components</term>
<term>Lupus</term>
<term>Lupus erythematosus</term>
<term>Older patients</term>
<term>Ophthalmological examination</term>
<term>Ophthalmological safety</term>
<term>Other drugs</term>
<term>Plasma concentrations</term>
<term>Renal</term>
<term>Renal failure</term>
<term>Retinal toxicity</term>
<term>Rheum</term>
<term>Rheumatic</term>
<term>Rheumatic diseases</term>
<term>Rheumatoid</term>
<term>Rheumatoid anhntis</term>
<term>Rheumatoid arthritis</term>
<term>Semin arthritis rheum</term>
<term>Serum chloroquine</term>
<term>Side effects</term>
<term>Systemic lupus erythematosus</term>
<term>Toxicity</term>
<term>Whole blood</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: The use of antimalarials in rheumatoid arthritis (RA) and systemic lupus erythematosis (SLE) has declined over recent years due to concern over retinal toxicity and the impression that this class of drugs is relatively ineffective in rheumatic diseases. Recent reviewsr‐3 suggest that this position should be changed. Firstly, there is now good evidence for the efficacy of these drugs in RA and secondly strict control of the daily dosage and careful ophthalmological surveillance can almost eliminate the risk of serious retinal toxicity.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Champion, G D" sort="Champion, G D" uniqKey="Champion G" first="G. D." last="Champion">G. D. Champion</name>
<name sortKey="Day, R O" sort="Day, R O" uniqKey="Day R" first="R. O." last="Day">R. O. Day</name>
<name sortKey="Graham, G G" sort="Graham, G G" uniqKey="Graham G" first="G- G." last="Graham">G- G. Graham</name>
<name sortKey="Sambrook, P" sort="Sambrook, P" uniqKey="Sambrook P" first="P." last="Sambrook">P. Sambrook</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003748 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003748 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:1873BE578436D6288E218D4FFFFF528745A73B2E
   |texte=   Antimalarials in Rheumatic Diseases
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

Antimalarials in Rheumatic Diseases

Antimalarials in Rheumatic Diseases

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri